FeaturesSignalPricingFounders
Log inGet started free
TB

TPG Biotech

Venture CapitalActive

TPG Biotech is a growth-stage equity and venture investment platform focused on the biotechnology industry.

San Francisco, United StatesFounded 1996
60
Investments
9
Exits
$1.2B
AUM
15.0%
Exit Rate

Get contact info, warm intros & fit scores

Sign up to unlock emails, Signal intro paths, and personalized fit analysis for TPG Biotech.

Get started free

Investment Thesis & Strategy

TPG Biotech invests in growth-stage biotechnology companies, leveraging its expertise to provide capital and strategic guidance to accelerate innovation and market leadership.

Notable Exits

CompanyTypeYearValue / Acquirer
Turning Point TherapeuticsAcquisition2022$4.1B
TesaroAcquisition2019$5.1B
MedivationAcquisition2016$14B
Kura OncologyIPO2014
Portola PharmaceuticalsIPO2013
ChimerixIPO2013
EpizymeIPO2013
Intercept PharmaceuticalsIPO2012
Acadia PharmaceuticalsIPO2004

Frequently Asked Questions

TPG Biotech focuses on Series A, Series B, Series C+ stage investments.

Related Investors